NewsFeed
Headlines ASRM ESHRE FIGO ACOG Fertility and Sterility PCOS
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Shweta Rajani Goswami։ We Have to Call Experimental Fertility Treatments Experimental
Shweta Rajani Goswami/zeevafertility.com
Sep 25, 2026, 16:32

Shweta Rajani Goswami։ We Have to Call Experimental Fertility Treatments Experimental

Shweta Rajani Goswami, Founder and Medical Director of  Zeeva Fertility, shared on LinkedIn։

“I am not against experimental fertility treatments.

I think we just have to call them experimental.

Because medical science evolves like this.

New treatments come in. We try them. We study them. We see which patients may actually benefit. And sometimes, after years of research, they become part of regular treatment.

There is nothing wrong with that.

The problem starts when we give an experimental treatment to a patient as though we already know it works.

I see this particularly with what is now being called ovarian rejuvenation.

PRP. Stem cell therapies. Other newer treatments being offered to women with very low ovarian reserve.

And I can understand why a woman wants to try them.

When somebody has been told that her egg reserve is very low, and that she may eventually have to consider donor eggs, she wants to try everything possible before reaching that point.

Of course she does.

But that is exactly why we have to be very, very clear with her.

This is experimental.

  • We are still studying it.
  • We do not know with certainty which patient will benefit.
  • We do not know that doing the procedure will improve the final outcome.

And it may still mean money, another procedure, and, importantly in fertility, time.

I am not saying nobody should do it.

There is no problem if a patient understands all of this and then says, ‘I still want to give it a try before I move on.’

That is her decision.

But it has to be an informed decision.

And I think sometimes we reduce informed consent to a form that a patient signs before a procedure.

For me that is not enough.

The patient sitting in front of us has to understand what we know.
She also has to understand what we don’t know.

  • What are the possible benefits?
  • What are the limitations?
  • What other options does she have?
  • And what may happen if this treatment does not work?

Because after hearing all of this, two patients may make completely different decisions.

One may still want to try the experimental treatment.

Another may decide that she does not want to lose more time and would rather move to the next option.

Both decisions can be reasonable.

What is not reasonable is allowing the patient to believe that an experimental treatment has the same evidence behind it as an established one.

Medical science will continue to experiment. It has to.

But the experimentation should never be hidden from the patient.

We should put the uncertainty on the table.

And then let the patient make her decision knowing exactly what she is choosing.”

Shweta Rajani Goswami։ We Have to Call Experimental Fertility Treatments Experimental

Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.

Experimental Fertility Treatment Fertility Fertility News Fertility treatment OBGYN reproductive health Reproductive Medicine Shweta Rajani Goswami Women’s Health
NewsFeed